SCHEMBL6703552

SCHEMBL6703552

O=C(CN(F)Cc1ccccc1)Nc1n[nH]c2cc(Cl)ccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 12/20 0.60
AURKB Q96GD4 2/20 0.49
STK17A Q9UEE5 1/20 0.49
HDAC1 Q13547 4/20 0.46
HDAC2 Q92769 4/20 0.46
HDAC8 Q9BY41 4/20 0.46
CDK2 P24941 4/20 0.46
CDK1 P06493 2/20 0.44
MAPK8 P45983 1/20 0.44
MAPK10 P53779 1/20 0.44
CDC7 O00311 1/20 0.43
IKBKB O14920 1/20 0.43
MAPK13 O15264 1/20 0.43
DAPK3 O43293 1/20 0.43
DYRK3 O43781 1/20 0.43
ROCK2 O75116 1/20 0.43
PRKD3 O94806 1/20 0.43
PIM1 P11309 1/20 0.43
PRKACA P17612 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1460269 0.83 GSK3B (0.70) GSK3BHDAC1HDAC2HDAC8CDK2
SCHEMBL1460369 0.81 GSK3B (0.74) GSK3BHDAC1HDAC2HDAC8CDK2
SCHEMBL27604440 0.81 GSK3B (0.74) GSK3BHDAC1HDAC2HDAC8CDK2
SCHEMBL6478310 0.79 GSK3B (0.64) GSK3BAURKBSTK17AHDAC1HDAC2
Trifluoroacetic Acid SCHEMBL6477736 0.78 GSK3B (0.65) GSK3BHDAC1HDAC2HDAC8CDK2
SCHEMBL27604435 0.77 GSK3B (0.61) GSK3BAURKBSTK17AHDAC1HDAC2
SCHEMBL1461244 0.76 GSK3B (0.76) GSK3BHDAC1HDAC2HDAC8
SCHEMBL1461358 0.76 GSK3B (1.00) GSK3BHDAC1HDAC2HDAC8
SCHEMBL6491225 0.75 GSK3B (0.82) GSK3BHDAC1HDAC2HDAC8
SCHEMBL6491066 0.74 FGFR1 (0.67) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487804-A2 AMINOINDAZOLE DERIVATIVES AS PROTEIN-KINASE INHIBITORS Aventis Pharma S.A. (FR) 2004-12-22 EP disclosed
WO-2003078403-A2 DERIVES D’AMINOINDAZOLES COMME INHIBITEURS DE PROTEINE-KINASE AVENTIS PHARMA S.A. (FR) 2003-09-25 WO disclosed